Immage Biotherapeutics Other Current Liabilities

Immage Biotherapeutics (IMMG) currently reports a other current liabilities of $110K as of February 2017. That compares with $70K in the prior-year period — up 58.9% year over year. Use the charts on this page to explore Immage Biotherapeutics's other current liabilities history and peer comparisons.

Immage Biotherapeutics's other current liabilities increased from $70K to $110K — a 58.9% year-over-year increase (period ending February 2017). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Immage Biotherapeutics reported $110K in other current liabilities as of February 2017. That compares with $70K in the prior-year period — up 58.9% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current other current liabilities of $110K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Immage Biotherapeutics, and consider following IMMG for alerts when major investors trade the stock.